logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Histamine-2 Receptor Antagonist class drugs

    FiltersReset Filters
    3 results

    • famotidine

      (Famotidine)
      Alembic Pharmaceuticals Inc.
      Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive GERD, and erosive esophagitis due to GERD in patients 40 kg and greater. In adults, they are also used for pathological hypersecretory conditions and to reduce the risk of duodenal ulcer recurrence.

    • famotidine

      (Famotidine)
      Ajanta Pharma USA Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis, hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including in infants from birth.

    • famotidine

      (Famotidine)
      Lupin Pharmaceuticals, Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic nonerosive GERD, erosive esophagitis due to GERD, pathological hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including infants.